Target intelligence / Profile preview

Oxidoreductase acting on CH-NH group donor

Molecular classification
Enzyme, Oxidoreductase
01

Overview

Oxidoreductases acting on CH-NH group donors are enzymes classified under EC 1.5 in the Enzyme Commission numbering system[1][3][5]. They catalyze oxidation-reduction (redox) reactions in which a substrate containing a CH-NH group (such as a secondary amine) acts as a hydrogen or electron donor and generates a C=N double bond as the primary product[6][8]. This class is diverse, covering dehydrogenases that act on various substrates and use different physiological acceptors including NAD(+), NADP(+), oxygen, disulfides, flavins, quinones, or iron-sulfur proteins[2][5]. EC 1.5 oxidoreductases play important roles in intermediary metabolism, amino acid catabolism, product detoxification, cell signaling, and neurotransmitter regulation. Individual enzymes in this class (such as monoamine oxidase or sarcosine dehydrogenase) are drug targets and studied for their role in diseases, but the EC 1.5 group itself refers to a mechanistic class rather than a single molecular entity[1][3][6].

Other names
EC 1.5 oxidoreductaseEC 1.5 enzymeDehydrogenase acting on CH-NH group donorAmino group oxidoreductase
02

Mechanism of action

Inhibition or modulation of redox enzymatic activity; Alteration of substrate dehydrogenation

03

Biological functions

Oxidation-reduction (redox) reactionsCatalysis of dehydrogenation of secondary amines
04

Disease associations

CancerCardiovascular diseaseNeurodegenerationOther (role depends on specific substrate and pathway)

Beyond the preview

Go deeper on Oxidoreductase acting on CH-NH group donor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidoreductase acting on CH-NH group donor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call